AI assistant
InspireMD, Inc. — Director's Dealing 2024
Jun 8, 2024
34187_dirs_2024-06-07_ff7a9f12-4925-4bd1-a2e4-f2b83246411f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: InspireMD, Inc. (NSPR)
CIK: 0001433607
Period of Report: 2024-06-05
Reporting Person: Stuka Paul (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-06-05 | Common Stock | X | 87500 | $1.3827 | Acquired | 336034 | Indirect |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2024-06-05 | Series H Warrant (right to buy) | $1.3827 | X | 87500 | Disposed | 2024-06-26 | Common Stock (87500) | Indirect |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 311548 | Direct |
Footnotes
F1: These securities are held by Osiris Investment Partners, L.P. ("Osiris"). The Reporting Person serves as the managing member of Osiris Partners, LLC, the general partner of Osiris. In such capacity, the Reporting Person may be deemed to beneficially own the reported securities. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein, and the inclusion of such securities in this report shall not be deemed an admission of beneficial ownership for purposes of Section 16 or for any other purposes. No transaction has been effected by the Reporting Person with respect to these securities, and they are being included in this Form 4 for informational purposes only.